Source: https://www.streetinsider.com/Corporate+News/Seres+Therapeutics+%28MCRB%29+Presents+New+Preclinical+Data+Supporting+the+Development+of+Microbiome+Therapeutics+for+Immuno-Oncology+at+AACR/14063477.html